Press release
Strategies Towards HIV Cure Announced
The Steering and Scientific Committees of the forthcoming ‘International HIV Persistence Workshop’ have just recently announced the preliminary program of this meeting which is dedicated towards finding a cure against HIV and AIDS.Tucker, GA, April 08, 2011 -- Even if most HIV-infected patients treated with highly active anti-retroviral therapy (ART) are quite well today, compliance, toxicity, and cost are major concerns. Furthermore, each time ART is stopped, plasma viremia rebounds because HIV always remains dormant in some reservoirs. This long-term persistence of HIV in an infected body means that ART must be taken life-long. Finally, the HIV pandemic remains very active with more than 33 million infected individuals worldwide et 7,000 daily new cases of HIV infection. Most of these patients reside in poor-resource countries where less than 40% of them have access to ART.
In this context, finding a way to control HIV replication without permanently taking ART is gaining major importance in the scientific community where the term ‘cure’ is no longer banished. This hard task needs to connect basic scientists with clinical scientists, and bring researchers from different fields. These are the principles of the ‘International HIV Persistence Workshop’ since its first edition in 2003. This biennial meeting welcomes more than 150 scientists actively involved in HIV persistence and reservoirs research, allowing them to discuss their findings and shape future projects. Governmental agencies, private foundations and pharmaceutical companies are also part of the process which tackles research from animal models to human gene therapy.
The workshop is organized by those who actively conduct this research such as Doctor Alain Lafeuillade (Toulon, France), Mario Stevenson (Miami, USA), David Margolis (Chapel Hill, USA), Tae-Wook Chun (Bethesda, USA)
Contact:
Alain Lafeuillade, MD, Informed Horizons, LLC, 1860 Montreal Road, Suite 2, Tucker, GA 30084 USA, 1-770-573-3020
lafeuillade@orange.fr, http://hiv-workshop.com/workshop-2011.htm
Contact:
Alain Lafeuillade
Informed Horizons, LLC
1860 Montreal Road, Suite 2
Tucker, GA 30084 USA
1-770-573-3020
lafeuillade@orange.fr
http://hiv-workshop.com/workshop-2011.htm
The workshop is organized by those who actively conduct this research such as Doctor Alain Lafeuillade (Toulon, France), Mario Stevenson (Miami, USA), David Margolis (Chapel Hill, USA), Tae-Wook Chun (Bethesda, USA)
Contact:
Alain Lafeuillade
Informed Horizons, LLC
1860 Montreal Road, Suite 2
Tucker, GA 30084 USA
1-770-573-3020
lafeuillade@orange.fr
http://hiv-workshop.com/workshop-2011.htm
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Strategies Towards HIV Cure Announced here
News-ID: 170205 • Views: …
More Releases from Informed Horizons, LLC
Scientists Move Towards A HIV Cure
Dr. Alain Lafeuillade and Dr. Mario Stevenson, are pleased to announce the 5th International Workshop on HIV Persistence During Therapy, to be held December 6-9, 2011 in St Maarten, West Indies. The Workshop will be of invaluable importance for scientists working towards a HIV cure.
Toulon, France, May 29, 2011 -- Dr. Alain Lafeuillade, Toulon, France and Dr. Mario Stevenson, University of Miami, USA are pleased to announce the 5th International…
Hope for a Cure Against HIV
Alain Lafeuillade (France) and Mario Stevenson (USA) co-authored a paper on HIV reservoirs that claims these reservoirs are the main hurdle to achieving HIV eradication. This paper provides information on the mechanisms of HIV persistence and a discussion on the critical questions facing researchers in the field.
Tucker, GA, May 28, 2011 -- Alain Lafeuillade (France) and Mario Stevenson (USA) co-authored a paper on HIV reservoirs that claims these reservoirs are…
New Discoveries Expected at the Scientific Workshop on HIV Reservoirs
Tucker, GA - April 21, 2011 -- Controlling HIV replication without the need of life-long antiretroviral therapy (ART) is the next frontier scientists are addressing. Researchers involved in the fields of HIV reservoirs and eradication have just released the preliminary program of a workshop they will organize later this year, where scientific breakthroughs are expected.
Fifteen years ago, when ART was discovered, a renewed optimism for a cure gained several scientists…
Researchers United to Find a HIV cure
HIV persistence is an area of importance to many scientists working on a possible cure for HIV, and every two years a reference workshop is held to bring the world's top scientists together for a meeting of the minds. Researchers from several different fields will therefore attend its next edition, December 6-9, 2011. The preliminary program of this workshop has just been released, and the four-day seminar is packed with…
More Releases for HIV
HIV-Associated Lipodystrophy Treatment Market - Increasing prevalence of HIV is …
HIV-associated lipodystrophy also known as lipodystrophy is a syndrome that occurs in HIV-infected patients. It is characterized by loss of subcutaneous fat from face, buttocks, arms and legs. Although the exact cause of HIV-associated lipodystrophy is not fully elucidated, some research evidence reported that it occurs in HIV-infected patients who are under antiretroviral medications. According to an article published in National Center for Biotechnology Information (NCBI) in 2014, prevalence of…
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication…
HIV Therapeutics Market– South Africa's Aspen launches three-in-one HIV drug
Recent Developments
Aspen Pharma care, a South Africa’s drug maker has launched a triple combination of tablet for the treatment of HIV in the country where the HIV virus is the most prevalent. The company's new Emdolten drug is a once a day tablet which is in the form of dolutegravir, an antiretroviral medication that balances the drug’s resistance. The company has launched Aspen Stavudine which was its first generic ARV…
HIV Vaccine Market HIV Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
Introduction to Human Immunodeficiency Virus (HIV) Vaccines
1.1 Overview
1.2 Antiquity of HIV Vaccine
Need for the Development of HIV Vaccine
Primer of HIV inside the Body
3.1 Inclusion of HIV Virus into the System
3.2 Interaction of HIV with Host
3.3 Eradication of HIV Virus
HIV Vaccine Development Process
4.1 Introduction
…
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways…
Hidden HIV Revealed: New Insights Into Latent HIV Infections
In spite of ever more effective therapies, HIV keeps managing to survive in the body. A comprehensive project conducted by the Austrian Science Fund FWF has clarified the molecular processes which contribute to this effect. In the process, approaches were discovered for possible therapies to combat the hidden reservoir formed by the virus.
Thanks to modern therapies, HIV infections have become controllable – but these treatments cannot provide a cure. Antiretroviral…
